Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
20. July 2026
Search
medline.ch
Oncology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 97833
Articles 1 - 20 / 1956660
The peak distress thermometer as a potent prognostic indicator for five-year survival in patients with hypopharyngeal cancer.
Eur Arch Otorhinolaryngol
Hsu CM.
PMID: 42472947 [PubMed - as supplied by publisher]
Medullary thyroid carcinoma diagnosis based on microRNA analysis: a case report.
Eur Arch Otorhinolaryngol
Borkhetaria PP, Sayeed S, Nurimba M, Stanisce L, Finkelstein SD, Chai RL.
PMID: 42472926 [PubMed - as supplied by publisher]
Sexual experience of urostomy patients with bladder cancer: a qualitative explorative study.
Sci Rep
Tian H, Han X.
PMID: 42472899 [PubMed - as supplied by publisher]
Optimising Radiologist Performance in Cancer Detection on Mammograms: The Impact of Weekly Reading Hours and Test Set Experience on BreastScreen and Non-BreastScreen Readers.
J Cancer Educ
Wells J, Trieu PDY, Barron ML, Stephens D, Awwad DA, Lewis SJ.
PMID: 42472897 [PubMed - as supplied by publisher]
The ferroptosis-related LncRNA CASC9 reveals its potential as a diagnostic and prognostic biomarker in esophageal squamous cell carcinoma.
Sci Rep
Yaoyao W, Qingfeng L, Liyou H, Lu X, Junxing H, Zihao L.
PMID: 42472876 [PubMed - as supplied by publisher]
Non-coding RNA-mediated ferroptosis reprogramming in doxorubicin-resistant breast cancer: mechanistic evidence, subtype vulnerabilities, and translational strategies.
World J Surg Oncol
Yu X, Xu A, Yao L, Huang X, Wang J, Li C, Fu D.
PMID: 42472836 [PubMed - as supplied by publisher]
High-intensity interval training in cancer patients: a bayesian meta-analysis of effects on VO(2)max, dose-response, and adherence.
BMC Sports Sci Med Rehabil
Zhang J, Tao J, Teo FLW, Teo MXY.
PMID: 42472833 [PubMed - as supplied by publisher]
RNA modifications in cancer: regulators of tumor evolution and therapeutic response.
Mol Cancer
Gu X, He Y, Xu Z, Zhang S, Liu Y, Yang Z, Liu H, Chen W, Zhang L, Xie Y, Hu J, Xing H, Yan J, Shi Q.
PMID: 42472832 [PubMed - as supplied by publisher]
Tumor evolution: signaling pathways, molecular mechanisms and therapeutic targets.
Signal Transduct Target Ther
Zhang KY, Zhu XZ, Yan YX, Ying XH, Zhang J, Wang ZH.
PMID: 42472831 [PubMed - indexed for MEDLINE]
Exosomes in cancer drug resistance: dual roles in therapy failure and emerging precision therapeutics.
Cancer Cell Int
Tegegne BA, Belew H, Teffera ZH, Belayneh M, Abebaw D, Fikrie M, Jemal M, Baylie T, Tadesse F, Wondm SA, Zeleke TK, Belay WY.
PMID: 42472816 [PubMed - as supplied by publisher]
Preoperative Radiologic Assessment of the Axilla in Locally Advanced Breast Cancer After Neoadjuvant Systemic Therapy: A Contemporary Comparison.
Ann Surg Oncol
Seto A, Port E, Bernik S, Sheng T, Balija T.
PMID: 42472753 [PubMed - as supplied by publisher]
The Role of Locoregional Treatment in Non-Progressive De Novo Metastatic Breast Cancer under Systemic Treatment: A Randomized Controlled Trial (LTMBC).
Ann Surg Oncol
Omranipour R, Eslami B, Alipour S, Nazarian N, Shahi F, Mirzania M, Mousavi K, Elahi A, Vasigh M.
PMID: 42472751 [PubMed - as supplied by publisher]
Bioinformatics reveals the prognostic potential of manganese metabolism-related genes in lung adenocarcinoma.
Funct Integr Genomics
Zha J, Liu X, Gao S, He J, Zhang Z.
PMID: 42472729 [PubMed - indexed for MEDLINE]
Application of ultrasound combined with microbubbles in conversion therapy for advanced liver cancer.
Sci Rep
Zhou H, Chen Z, Zhong X, Yuan G, Zhou Y, Wang J, Xu X.
PMID: 42472707 [PubMed - as supplied by publisher]
Association Between Treatment Sequencing and Overall Survival in Stage IV NSCLC With Brain Metastases: A National Cancer Database Study.
Thorac Cancer
Shah A, Gwalani P, Zhai M, Goyal R, Kra J.
PMID: 42472632 [PubMed - indexed for MEDLINE]
ADT combinations with radiation for prostate cancer: A systematic review and meta-analysis.
Int J Radiat Oncol Biol Phys
Takayesu JSK, Xie T, Aldous J, Nasser B, Alumkal JJ, Dess RT, Reichert ZR, Schipper MJ, Spratt D, Suresh K, Jackson WC.
PMID: 42472616 [PubMed - as supplied by publisher]
Redox-activated heavy-atom-free photosensitizers for enhanced photodynamic cancer therapy.
Adv Drug Deliv Rev
Jeong H, Song H, Nguyen VN, Park J, Yoon J.
PMID: 42472603 [PubMed - as supplied by publisher]
Biomimetic Nanoparticles for Metastatic Breast Cancer: Advancing Targeted Drug Delivery Beyond Conventional Nanomedicine.
Crit Rev Oncol Hematol
Rehman U, Dongsar TS, Dongsar TT, Hasan N, Ahmed FJ, Kesharwani P.
PMID: 42472562 [PubMed - as supplied by publisher]
Protein arginine methyltransferase (PRMT8) in cancer: Genomic alterations, subcellular dynamics, and clinical implications.
Crit Rev Oncol Hematol
Ting CY, Loon SGS, Sun LB, Pin KB.
PMID: 42472561 [PubMed - as supplied by publisher]
Nomogram of conditional survival probability in oldest old patients with colorectal cancer after surgical resection: a multicenter retrospective cohort study.
Jpn J Clin Oncol
Sugiura K, Sato E, Aoyama J, Kishida N, Kikuchi H, Okabayashi K, Aiko S, Kitagawa Y.
PMID: 42472545 [PubMed - as supplied by publisher]
Articles 1 - 20 / 1956660
Page 1 of 97833
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy